Systematic review of 7 trials (374 adults with cancer; 6 trials, 272 patients meta-analysed): high-flow nasal oxygen improved dyspnoea vs other oxygen or air devices (SMD -0.60); in subgroup analysis improvement was seen only in hypoxaemic patients. Mostly high risk of bias.
Meta-analysisn = 374
Hentsch et al. High-flow nasal oxygen for the relief of persistent dyspnea in adult patients with cancer: A systematic review and meta-analysis